Skip to main content

Find Clinical Trials

Home
Conditions
Oligoprogressive

Clinical trial condition

Oligoprogressive

Explore clinical trials studying Oligoprogressive. Study availability and eligibility vary by location and protocol.

9 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Oligoprogressive trial results

Recruiting

COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study

NCT05301881

Conditions: Breast Cancer Invasive, Metastatic Cancer, Neoplasm Metastasis, +5 more
Locations: Noordwest Ziekenhuisgroep Alkmaar, Netherlands

Antoni van Leeuwenhoek Amsterdam, Netherlands

Rijnstate Arnhem, Netherlands

Deventer ziekenhuis Deventer, Netherlands

View Trial Details

Recruiting

Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer

NCT04989725

Conditions: Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +4 more
Locations: Centre Hospitalier de l'Université de Montréal Montreal, Quebec, Canada

View Trial Details

Recruiting

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

NCT06103682

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: University of California, Davis Sacramento, California, United States

View Trial Details

Recruiting

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

NCT06103669

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
Locations: University of California, Davis Sacramento, California, United States

View Trial Details

Recruiting

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

NCT06101277

Conditions: Adenocarcinoma, Appendiceal Cancer, Appendiceal Neoplasms, +28 more
Locations: University of California, Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Recruiting

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

NCT06101290

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
Locations: University of California, Davis Sacramento, California, United States

View Trial Details

Recruiting

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

NCT04974671

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Recruiting

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

NCT06585007

Conditions: Castration-resistant Prostate Cancer, Oligoprogressive
Locations: University Hospitals Leuven Leuven, Belgium

View Trial Details

Recruiting

Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer

NCT04838899

Conditions: Castration-resistant Prostate Cancer, Oligoprogressive
Locations: Odette Cancer Centre Toronto, Ontario, Canada

View Trial Details